3
Announcements
Trials
Browse
Landscape
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Sarcoma
1
Other solid neoplasm
1
Other hematologic neoplasm
1
Gynecologic
1
Gastrointestinal
1
Conditions
Neoplasms
1
Hematologic Neoplasms
1
Cardiovascular Diseases
1
Interventions
venetoclax
73
Specimen Handling
66
Cyclophosphamide
58
Cytarabine
50
Biopsy
49
fludarabine
42
Azacitidine
37
Rituximab
28
fludarabine phosphate
21
blinatumomab
20
Methotrexate
20
Magnetic Resonance Spectroscopy
20
Daunorubicin
20
Vincristine
19
Prednisone
18
ibrutinib
16
Injections
16
Dexamethasone
16
decitabine and cedazuridine drug combination
15
Whole-Body Irradiation
15
Tacrolimus
14
Melphalan
14
Doxorubicin
14
Busulfan
14
obinutuzumab
13
acalabrutinib
13
Mycophenolic Acid
13
Granulocyte Colony-Stimulating Factor
13
merphos
12
Mercaptopurine
12
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Antineoplastic Agents
×
Other hematologic neoplasm
×
30 days
×
Clear all
NCT07621289
2026-06-02
EUCARTOXSCORES
University Hospital, Caen
Not yet recruiting
10,000 enrolled